Wang Shao-shuai, Qiao Fu-yuan, Feng Ling, Lv Juan-juan
Department of Obstetrics and Gynecology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
J Zhejiang Univ Sci B. 2008 Feb;9(2):93-9. doi: 10.1631/jzus.B0710599.
To explore the relationship between genetic polymorphisms in methylenetetrahydrofolate reductase (MTHFR), methionine synthase reductase (MTRR), the central enzymes in folate metabolism that affects DNA methylation and synthesis, and the risk of Down syndrome in China.
Genomic DNA was isolated from the peripheral lymphocytes of 64 mothers of children with Down syndrome and 70 age matched control subjects. Polymerase chain reaction and restriction fragment length polymorphism were used to examine the polymorphisms of MTHFR 677C-->T, MTRR 66A-->G and the relationship between these genotypes and the risk of Down syndrome was analyzed.
The results show that the MTHFR 677C-->T polymorphism is more prevalent among mothers of children with Down syndrome than among control mothers, with an odds ratio of 3.78 (95% confidence interval (CI), 1.78 approximately 8.47). In addition, the homozygous MTRR 66A-->G polymorphism was independently associated with a 5.2-fold increase in estimated risk (95% CI, 1.90 approximately 14.22). The combined presence of both polymorphisms was associated with a greater risk of Down syndrome than the presence of either alone, with an odds ratio of 6.0 (95% CI, 2.058 approximately 17.496). The two polymorphisms appear to act without a multiplicative interaction.
MTHFR and MTRR gene mutation alleles are related to Down syndrome, and CT, TT and GG gene mutation types increase the risk of Down syndrome.
探讨亚甲基四氢叶酸还原酶(MTHFR)、甲硫氨酸合成酶还原酶(MTRR)这两种影响DNA甲基化和合成的叶酸代谢关键酶的基因多态性与中国唐氏综合征风险之间的关系。
从64名唐氏综合征患儿母亲及70名年龄匹配的对照者的外周淋巴细胞中提取基因组DNA。采用聚合酶链反应和限制性片段长度多态性方法检测MTHFR 677C→T、MTRR 66A→G的多态性,并分析这些基因型与唐氏综合征风险之间的关系。
结果显示,MTHFR 677C→T多态性在唐氏综合征患儿母亲中比对照母亲中更普遍,优势比为3.78(95%置信区间(CI),1.78至8.47)。此外,纯合的MTRR 66A→G多态性与估计风险增加5.2倍独立相关(95%CI,1.90至14.22)。两种多态性同时存在比单独存在一种多态性与更高的唐氏综合征风险相关,优势比为6.0(95%CI,2.058至17.496)。这两种多态性似乎没有相乘相互作用。
MTHFR和MTRR基因突变等位基因与唐氏综合征有关,CT、TT和GG基因突变类型增加了唐氏综合征的风险。